Victory Capital Management
SANA icon

Victory Capital Management’s Sana Biotechnology SANA Stock Holding History

Victory Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Sell
19,022
-76
-0.4% -$299 ﹤0.01% 2308
2025
Q4 		$77.7K Buy
19,098
+2,463
+15% +$11K ﹤0.01% 2294
2025
Q3 		$59.1K Buy
16,635
+1,677
+11% +$6.06K ﹤0.01% 2327
2025
Q2 		$40.8K Sell
14,958
-24
-0.2% -$50 ﹤0.01% 2396
2025
Q1 		$25.2K Sell
14,982
-162
-1% -$453 ﹤0.01% 2415
2024
Q4 		$24.7K Sell
15,144
-222
-1% -$662 ﹤0.01% 2434
2024
Q3 		$63.9K Sell
15,366
-199
-1% -$1.04K ﹤0.01% 2371
2024
Q2 		$85K Buy
15,565
+55
+0.4% +$438 ﹤0.01% 2314
2024
Q1 		$155K Buy
15,510
+2,170
+16% +$16.3K ﹤0.01% 2253
2023
Q4 		$54.4K Buy
+13,340
New +$49.1K ﹤0.01% 2428
2022
Q3 		– Sell
-12,524
Closed -$81K – 2764
2022
Q2 		$81K Sell
12,524
-29
-0.2% -$185 ﹤0.01% 2486
2022
Q1 		$95K Sell
12,553
-358
-3% -$2.9K ﹤0.01% 2525
2021
Q4 		$200K Sell
12,911
-335
-3% -$6.46K ﹤0.01% 2487
2021
Q3 		$298K Buy
13,246
+1,122
+9% +$23.6K ﹤0.01% 2386
2021
Q2 		$238K Buy
+12,124
New +$275K ﹤0.01% 2493

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Victory Capital Management's SANA Position: Q1 2026 in Review

Victory Capital Management reduced its Sana Biotechnology (SANA) stake by 0.4% in Q1 2026, selling an estimated $299 and leaving 19,022 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Victory Capital Management first reported a position in SANA in Q2 2021 and has held it in 15 quarters since. The position peaked at $298K in Q3 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Victory Capital Management held 19,022 shares of Sana Biotechnology worth $54.8K as of Q1 2026.
  • Victory Capital Management sold 76 Sana Biotechnology shares in Q1 2026, an estimated $299.
  • Sana Biotechnology made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2308 holding.
  • Victory Capital Management first reported a position in Sana Biotechnology in Q2 2021 and has held it in 15 quarters since.
  • Victory Capital Management's Sana Biotechnology position peaked at $298K in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.